文献速递生殖医学

冻胚移植前长期促性腺激素释放激素激动剂预处理改善子宫腺肌病女性的妊娠结局

Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis.
PubMed 文献 · Reprod Biomed Online · 2021-10-25

本研究纳入537例子宫腺肌病女性,分为三组:A组为长期促性腺激素释放激素激动剂(GnRHa)预处理后行冻胚移植(192例),B组为超长方案新鲜胚胎移植(241例),C组为长方案新鲜胚胎移植(104例)。A组促性腺激素总剂量和刺激持续时间显著低于B组和C组,着床率和活产率显著高于B组和C组。与C组相比,A组的着床率、临床妊娠率和活产率升高,流产率降低;与B组相比,A组冻胚移植是活产率的保护因素。

要点

  • 长期GnRHa预处理后冻胚移植的促性腺激素总剂量和刺激持续时间显著低于长方案或超长方案新鲜胚胎移植。
  • 长期GnRHa预处理后冻胚移植的着床率和活产率显著高于长方案或超长方案新鲜胚胎移植。
  • 与长方案新鲜胚胎移植相比,长期GnRHa预处理后冻胚移植的着床率、临床妊娠率和活产率升高,流产率降低。

核心结论

  • 长期GnRHa预处理后行冻胚移植的体外受精/卵胞浆内单精子注射结局更好,与长方案或超长方案新鲜胚胎移植相比,可能获益于更低的促性腺激素剂量和更短的刺激持续时间。

研究设计与样本

  • 研究纳入537例子宫腺肌病女性,分为三组:A组为长期GnRHa预处理后冻胚移植周期(192例),B组为超长GnRHa方案新鲜胚胎移植周期(241例),C组为长GnRHa方案新鲜胚胎移植周期(104例)。

主要发现

  • A组促性腺激素总剂量和刺激持续时间显著低于B组和C组,着床率和活产率显著高于B组和C组。
  • 与C组相比,A组着床率(OR 1.729,95%CI 1.073-2.788,P=0.025)、临床妊娠率(OR 1.665,95%CI 1.032-2.686,P=0.037)和活产率(OR 1.694,95%CI 1.045-2.746,P=0.033)升高,流产率(OR 0.203,95%CI 0.078-0.530,P=0.001)降低。
  • A组与B组比较,长期GnRHa预处理后冻胚移植是活产率的保护因素(OR 1.350,95%CI 1.017-1.792,P=0.038)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Do frozen embryo transfer (FET) cycles following long-term gonadotrophin-releasing hormone agonist (GnRHa) pretreatment have better pregnancy outcomes than fresh embryo transfer cycles with long or ultra-long GnRHa protocol in these patients? DESIGN: This study included 537 women with adenomyosis divided into three groups: (Group A) FET cycles following long-term GnRHa pretreatment (192 patients); (Group B) fresh embryo transfer cycles with the ultra-long GnRHa protocol (241 patients); (Group C) fresh embryo transfer cycles with the long GnRHa protocol (104 patients). RESULTS: The total gonadotrophin dose and stimulation duration were significantly lower in Group A than in Groups B and C. The implantation and live birth rates were significantly higher in Group A than in Groups B and C. In the long-term GnRHa pretreatment and FET treatment of Group A, implantation (odds ratio [OR] 1.729, 95% confidence interval [CI] 1.073-2.788, P = 0.025), clinical pregnancy (OR 1.665, 95% CI 1.032-2.686, P = 0.037) and live birth rates (OR 1.694, 95% CI 1.045-2.746, P = 0.033) increased and miscarriage rate (OR 0.203, 95% CI 0.078-0.530, P = 0.001) decreased when compared with Group C. Comparison of Groups A and B showed that with the long-term GnRHa pretreatment, FET was a protective factor for live birth rate (OR 1.350, 95% CI 1.017-1.792, P = 0.038). CONCLUSION: FET following long-term GnRHa pretreatment has a better IVF/intracytoplasmic sperm injection outcome, and a potential benefit in terms of a lower gonadotrophin dose, and a shorter stimulation duration than fresh embryo transfer combined with a long or ultra-long GnRHa protocol.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Wu Y, Huang J, Zhong G, et al. Long-term GnRH agonist pretreatment before frozen embryo transfer improves pregnancy outcomes in women with adenomyosis. Reprod Biomed Online. 2021. PMID: 34895827. doi:10.1016/j.rbmo.2021.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。